CYP27A1 and breast cancer: The significant associations between high intratumoral levels of CYP27A1 with aggressive breast tumor biological features seen in this study are consistent with previous reports [12, 39] and align with the preclinical evidence supporting a pathogenic role of the 27HC/CYP27A1 metabolic pathway in BC [12, 27, 43].